Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 275

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Five‐year survival after surgical treatment for kidney cancer: A population‐based competing risk analysis

Open access
Hollingsworth, John M., Miller, David C., Daignault, Stephanie, Hollenbeck, Brent K.·2007·Cancer

Abstract

BACKGROUND.: Kidney cancer's rising incidence is largely attributable to the increased detection of small renal masses. Although surgery rates have paralleled this incidence trend, mortality continues to rise, calling into question the necessity of surgery for all patients with renal masses. Using a population‐based cohort, a competing risk analysis was performed to estimate patient survival after surgery for kidney cancer, as a function of patient age and tumor size at diagnosis. METHODS.: With data from the Surveillance, Epidemiology, and End Results Program (1983–2002), a cohort was assembled of 26,618 patients with surgically treated, local‐regional kidney cancer. Patients were sorted into 20 age‐tumor size categories and the numbers of patients that were alive, dead from kidney cancer, and dead from other causes were tabulated. Poisson regression models were fitted to obtain estimates of cancer‐specific and competing‐cause mortality. RESULTS.: Age‐specific kidney cancer mortality was stable across all size strata but varied inversely with tumor size. Patients with the smallest tumors enjoyed the lowest cancer‐specific mortality (5% for masses ≤4 cm). Competing‐cause mortality rose with increasing patient age. The estimated 5‐year competing‐cause mortality for elderly subjects (≥70 years) was 28.2% (95% confidence interval [CI]: 25.9%–30.8%), irrespective of tumor size. CONCLUSIONS.: Despite surgical therapy, competing‐cause mortality for patients with renal masses rises with increasing patient age. After 5 years, one‐third of elderly patients (≥70 years) will die from other causes, suggesting the need for prospective studies to evaluate the role of active surveillance as an initial therapeutic approach for some small renal masses. Cancer 2007. © 2007 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.22600

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 275

Metadata

Authors
Hollingsworth, J. M., Miller, D. C., Daignault, S., & Hollenbeck, B. K.
Venue
Cancer
Publisher
Wiley
Published
2007-04-18
Volume
109
Issue
9
Pages
1763-1768
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2131595192
Cited by
275
References
17
FWCI
9.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Five‐year survival after surgical treatment for kidney cancer: A population‐based competing risk analysis. https://app.cochat.ai/papers/10.1002/cncr.22600
The paper
Hollingsworth, J. M., Miller, D. C., Daignault, S., & Hollenbeck, B. K. (2007). Five‐year survival after surgical treatment for kidney cancer: A population‐based competing risk analysis. Cancer. https://doi.org/10.1002/cncr.22600

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.